Skip to main content
Premium Trial:

Request an Annual Quote

Lab901 Raises $4M in Equity Funding

NEW YORK (GenomeWeb News) – Scottish DNA analysis firm Lab901 has raised £2.4 million ($4 million) in equity funding from a group of UK investors, the company said today.

Lab901 plans to use the financing to expand international sales of its ScreenTape analysis platform and to continue to develop its products.

The new funding came from Archangel Informal Investment, Alliance Trust Equity Partners, Scottish Enterprise, Foresight 3 VCT, and TriCapital.

The firm's ScreenTape platform is aimed at replacing manual analysis of proteins, DNA, and RNA, in infectious disease testing. It is now being sold in 20 countries in Asia, the Americas, Europe, and in Africa, through a network of 16 distribution partners.

The company said its Protein ScreenTape may be used in life sciences research and drug discovery for quality control during antibody production and for monitoring protein purification, and its DNA ScreenTape has applications in research as well as molecular diagnostic testing for infectious diseases.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.